Psychological aspects of living with HIV disease

Western Journal of Medicine

Volumn 175, Issue 5, 2001, Pages 332-335

  Remien, R H ^a,b   Rabkin, J G ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; FLUOXETINE; PAROXETINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL DECISION MAKING; MENTAL DISEASE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; REVIEW; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; VIRUS INFECTION;

COMORBIDITY; DECISION MAKING; DEPRESSION; HIV INFECTIONS; HUMANS; LIFE STYLE; PRIMARY HEALTH CARE;

EID: 0035157623     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.175.5.332     Document Type: Review

References (19)

1. Are advances in treatment changing views about high-risk sex?
2. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex
3. Who may be engaging in high-risk sex due to medical treatment advances?
4. 20 Years after AIDS emerges, HIV's complexities still loom large
5. Findings in psychiatric consultations with patients with acquired immune deficiency syndrome
6. Psychosocial reactions of persons with acquired immunodeficiency syndrome
7. Psychopathology in male and female intravenous drug users with and without HIV infection
8. Mood disorders in HIV infection: Prevalence and risk factors in nonepicenter of the AIDS epidemic
9. Severity of psychiatric symptoms after HIV testing
10. Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment
11. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection II. Standardized clinical assessment of current and lifetime psychopathology
12. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
13. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study
14. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health questionnaire
15. Randomized, placebo-contolled trial of paroxetine versus imipramine in depressed HIV-positive outpatients
16. Fluoxetine treatment for depression in patients with HIV and AIDS: A randomized, placebo-controlled trial
17. Treatment of major depression in HIV-seropositive men
18. Treating depression in HIV-positive patients